Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 211: All of the following are cellular vaccines except:

A. BCG
B. Measles vaccine
C. DPT
D. Tetanus toxoid (Correct Answer)

Explanation: ### Explanation The classification of vaccines is based on the nature of the antigen used to stimulate the immune system. Vaccines can be broadly categorized into **Cellular (Whole-cell)** vaccines and **Acellular (Subunit/Toxin-based)** vaccines. **Why Tetanus Toxoid is the correct answer:** Tetanus toxoid is **not a cellular vaccine**; it is a **toxoid**. It is prepared by detoxifying the exotoxin produced by *Clostridium tetani* using formaldehyde. The resulting product is an immunogenic protein (antigen) but does not contain the bacterial cell itself. Therefore, it is classified as an acellular, toxin-based vaccine. **Analysis of Incorrect Options:** * **BCG (Bacillus Calmette–Guérin):** This is a **Live Attenuated Bacterial** vaccine containing live, weakened cells of *Mycobacterium bovis*. Since it contains the whole bacterial cell, it is a cellular vaccine. * **Measles Vaccine:** This is a **Live Attenuated Viral** vaccine. It contains the whole (though weakened) virus particle, making it a cellular/whole-organism vaccine. * **DPT (Diphtheria, Pertussis, Tetanus):** While Diphtheria and Tetanus components are toxoids, the traditional **Pertussis** component (wP) in the DPT combination is a **killed whole-cell** vaccine. Thus, the DPT vaccine contains cellular components. **High-Yield Clinical Pearls for NEET-PG:** * **Toxoids:** Only two major toxoids are used in the routine immunization schedule: **Tetanus** and **Diphtheria**. * **Acellular Pertussis (aP):** Modern DTaP vaccines use purified components (like pertussis toxoid) instead of the whole cell to reduce febrile seizures and local reactions. * **Freeze Sensitivity:** Tetanus toxoid is highly sensitive to freezing (must be stored at +2°C to +8°C). If frozen, it loses potency (confirmed by the **Shake Test**). * **Route:** Tetanus toxoid is always administered **Intramuscularly (IM)**.

Question 212: What percentage of herd immunity is considered necessary to prevent epidemic spread of diphtheria?

A. 50%
B. 55%
C. 60%
D. 70% (Correct Answer)

Explanation: **Explanation:** **Herd Immunity** (Community Immunity) refers to the resistance of a group to the spread of an infectious disease based on the proportion of immune individuals in the population. For **Diphtheria**, the critical threshold required to prevent an epidemic is **70%**. 1. **Why 70% is Correct:** The herd immunity threshold is determined by the basic reproduction number ($R_0$) of the pathogen. For *Corynebacterium diphtheriae*, the $R_0$ typically ranges between 6 and 7. To halt transmission, the proportion of the population that must be immune is calculated using the formula: $H = 1 - (1/R_0)$. For Diphtheria, epidemiological studies have consistently shown that when the immunity level in a community reaches **70%**, the chain of transmission is effectively broken, preventing large-scale outbreaks. 2. **Analysis of Incorrect Options:** * **50% - 60% (Options A, B, C):** These levels are insufficient for Diphtheria. While a 50-60% immunity level may slow down transmission, it remains below the critical threshold, leaving enough susceptible individuals to sustain an epidemic. These lower percentages are more characteristic of diseases with lower $R_0$ values. 3. **High-Yield Clinical Pearls for NEET-PG:** * **Measles:** Requires the highest herd immunity threshold (**94-95%**) due to its very high $R_0$ (12-18). * **Pertussis:** Requires approximately **92-94%**. * **Polio & Mumps:** Require approximately **80-85%**. * **Smallpox:** Required **80-85%** (historical context for eradication). * **Note:** Herd immunity does not protect against **Tetanus**, as it is not a communicable disease (no person-to-person spread).

Question 213: What is the study design used for studying the relationship between consanguineous marriage and genetic abnormalities?

A. Twin study
B. Family study
C. Case control study
D. Nested case control study (Correct Answer)

Explanation: ### Explanation **Why Nested Case Control Study is Correct:** A **Nested Case Control Study** is the ideal design for studying the relationship between consanguineous marriage and genetic abnormalities because it combines the benefits of both cohort and case-control designs. In this scenario, a cohort of pregnant women or newborns is followed over time. As genetic abnormalities (the outcome) occur, these individuals become "cases." For every case, one or more "controls" are selected from the same cohort who have not yet developed the abnormality. Researchers then look back at the exposure (consanguinity). This design is highly efficient for studying rare genetic outcomes within a defined population, reduces selection and information bias, and is more cost-effective than a full prospective cohort study. **Why Other Options are Incorrect:** * **Twin Study:** These are used to differentiate between the effects of genetics (nature) and environment (nurture) by comparing monozygotic and dizygotic twins. They do not specifically measure the impact of consanguinity. * **Family Study:** While these look at the clustering of diseases within families (genetic epidemiology), they are primarily used to determine the mode of inheritance (e.g., autosomal dominant vs. recessive) rather than establishing a statistical association between an exposure like consanguinity and an outcome. * **Case Control Study:** While possible, a traditional case-control study is prone to **recall bias** regarding family history and selection bias, making it less robust than a nested design. **High-Yield NEET-PG Pearls:** * **Nested Case Control:** Also known as a "case-control study within a cohort." * **Key Advantage:** It eliminates **selection bias** because cases and controls come from the same pool. * **Consanguinity:** Increases the risk of **autosomal recessive** disorders due to increased homozygosity. * **Ecological Study:** Uses "populations" or "groups" as the unit of study (often tested alongside these designs).

Question 214: What is the definition of prospective screening?

A. A person screened for their own benefit.
B. A person screened for the benefit of others. (Correct Answer)
C. Neonatal screening is an example of prospective screening.
D. None of the above.

Explanation: ### Explanation **Concept Overview** In epidemiology, screening is categorized based on the objective and the target population. **Prospective screening** (also known as **proactive screening**) refers to the screening of individuals not for their own direct health benefit, but to protect the health of others or the community at large. **Why Option B is Correct** Prospective screening is designed to identify carriers or infected individuals who could potentially transmit a disease to a vulnerable population. The primary goal is **public health safety** rather than individual treatment. * **Example:** Screening an immigrant for tuberculosis or a food handler for typhoid. The intervention protects the community from an outbreak, even if the individual being screened is asymptomatic. **Analysis of Incorrect Options** * **Option A:** A person screened for their own benefit is termed **Presymptomatic Screening**. The goal here is early detection and treatment to improve the individual's prognosis (e.g., Pap smear for cervical cancer or mammography). * **Option C:** Neonatal screening is actually an example of **Presymptomatic Screening**. It is performed to detect metabolic disorders (like Phenylketonuria) early enough to treat the infant and prevent permanent damage. It does not fall under prospective screening because it benefits the child directly. **High-Yield Clinical Pearls for NEET-PG** * **Mass Screening:** Screening of the whole population (or a large subgroup) regardless of risk (e.g., BP check in a camp). * **High-Risk/Selective Screening:** Screening only those at increased risk (e.g., screening smokers for lung cancer). * **Opportunistic Screening:** Screening a patient who has come to the doctor for an unrelated complaint (e.g., checking BP of a patient presenting with a fracture). * **Multiphasic Screening:** Using two or more screening tests simultaneously for a large group of people.

Question 215: What is the definition of impairment?

A. Loss of anatomic structure (Correct Answer)
B. Inability to perform an activity
C. Failure of fulfillment of a normal role
D. Abnormal condition in the body

Explanation: ### Explanation The WHO defines the progression of a disease outcome through the sequence: **Disease → Impairment → Disability → Handicap**. **1. Why the Correct Answer is Right:** **Impairment** is defined as any loss or abnormality of psychological, physiological, or anatomical structure or function. It represents a disturbance at the **organ level**. In this question, "Loss of anatomic structure" (Option A) directly aligns with the WHO definition of impairment (e.g., a missing limb or a scarred retina). **2. Analysis of Incorrect Options:** * **Option B (Inability to perform an activity):** This defines **Disability**. Disability is any restriction or lack of ability to perform an activity in a manner considered normal for a human being. It represents a disturbance at the **personal level** (e.g., inability to walk due to a missing limb). * **Option C (Failure of fulfillment of a normal role):** This defines **Handicap**. A handicap is a disadvantage resulting from an impairment or disability that limits or prevents the fulfillment of a role that is normal for that individual. It represents a disturbance at the **societal level** (e.g., unemployment due to inability to walk). * **Option D (Abnormal condition in the body):** This is a generic description of **Disease** or pathology, which is the starting point of the sequence. **3. High-Yield Clinical Pearls for NEET-PG:** * **Sequence:** Disease (Intrinsic) → Impairment (Organ level) → Disability (Personal level) → Handicap (Social level). * **Key Distinction:** If a person loses a leg in an accident: * The loss of the leg is the **Impairment**. * The inability to walk is the **Disability**. * The inability to hold a job as a delivery driver is the **Handicap**. * **Rehabilitation** aims to reduce the impact of disability and handicap, even if the impairment is permanent.

Question 216: If the gene frequency for an X-linked recessive disease is 1 in 1,000 in the general population, what is the frequency of affected males in this population?

A. 1 in 10
B. 1 in 100
C. 1 in 500
D. 1 in 1,000 (Correct Answer)

Explanation: ### Explanation **1. Why the Correct Answer is Right (The Concept)** The question is based on the **Hardy-Weinberg Principle**, which describes the relationship between allele frequencies and genotype frequencies in a population. * Let **$q$** be the frequency of the recessive allele (disease gene). * In **X-linked recessive** disorders, males are hemizygous (they have only one X chromosome). Therefore, a male is affected if he carries just one copy of the recessive gene. * The frequency of affected males is equal to the gene frequency itself: **Frequency of affected males = $q$**. * Given $q = 1/1,000$, the frequency of affected males is **1 in 1,000**. **2. Why the Incorrect Options are Wrong** * **Options A (1 in 10) and B (1 in 100):** These values are mathematically unrelated to the given gene frequency ($10^{-3}$). * **Option C (1 in 500):** This might be a distractor for those confusing gene frequency with carrier frequency or assuming males represent only half the population, but in Hardy-Weinberg terms, the male genotype frequency directly mirrors the allele frequency. * **Note on Females:** For an X-linked recessive disease, a female must have two copies to be affected. Her frequency would be **$q^2$** ($1/1,000 \times 1/1,000 = 1$ in $1,000,000$), which is significantly rarer. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **Autosomal Recessive:** Frequency of affected individuals = $q^2$; Frequency of carriers (heterozygotes) = $2pq$ (approx. $2q$ if $q$ is very small). * **X-linked Recessive Rule of Thumb:** The prevalence of the disease in males is the best clinical estimate of the gene frequency ($q$) in that population. * **Examples of X-linked Recessive Disorders:** Hemophilia A and B, Duchenne Muscular Dystrophy, and Color Blindness. * **Hardy-Weinberg Equilibrium** assumes a large population, random mating, no mutation, no selection, and no migration.

Question 217: What represents the prognosis of a disease?

A. Secondary attack rate
B. Incubation period (Correct Answer)
C. Latency
D. Serial interval

Explanation: **Explanation:** The **Incubation Period** is the interval between the entry of an infectious agent into a host and the appearance of the first clinical sign or symptom. It represents the **prognosis** of a disease because the length of the incubation period often correlates with the severity and clinical course. A short incubation period often predicts a more acute or severe clinical onset, while a long incubation period suggests a more chronic or insidious progression. It also helps in determining the period of surveillance and the timing of prophylactic interventions. **Analysis of Incorrect Options:** * **Secondary Attack Rate (SAR):** This measures the **infectivity** or communicability of a disease. It is the number of exposed persons who develop the disease within the incubation period following exposure to a primary case. * **Latency (Latent Period):** This is the time from the point of infection to the point when the individual becomes **infectious** (able to transmit the disease). In many chronic diseases, it refers to the period between exposure to a risk factor and the clinical manifestation. * **Serial Interval:** This is the time gap between the onset of the primary case and the onset of the secondary case. It represents the **generation time** and helps in estimating the spread of an epidemic. **High-Yield NEET-PG Pearls:** * **Median Incubation Period:** The time required for 50% of cases to occur. * **Quarantine Period:** Usually calculated as the **maximum** incubation period of a disease. * **Extrinsic Incubation Period:** The time taken for an infectious agent to develop/multiply inside an arthropod vector before it becomes infective to humans (e.g., Malaria in mosquitoes).

Question 218: Which of the following is NOT a disadvantage of a cohort study?

A. Cohort studies involve a large number of people.
B. Cohort studies can be expensive.
C. Recall bias is a disadvantage. (Correct Answer)
D. Attrition is a disadvantage.

Explanation: In epidemiology, understanding the distinction between prospective and retrospective study designs is crucial for the NEET-PG. ### **Explanation of the Correct Answer** **Recall bias** is primarily a disadvantage of **Case-Control studies**, not Cohort studies. In a Case-Control study, participants are asked to remember past exposures after the disease has already occurred, leading to potential inaccuracies. In a **Prospective Cohort study**, data on exposure are collected at the beginning of the study *before* the disease develops. Therefore, the reliance on memory for exposure status is eliminated, making recall bias virtually non-existent. ### **Analysis of Incorrect Options** * **A. Large number of people:** This is a true disadvantage. To achieve statistical significance, especially for rare outcomes, cohort studies require a massive sample size to ensure enough "events" occur over time. * **B. Expensive:** Due to the large sample size and the necessity of long-term follow-up (often spanning years or decades), cohort studies require significant financial resources and administrative overhead. * **D. Attrition:** Also known as "Loss to Follow-up," this is a major disadvantage. Over time, participants may migrate, lose interest, or die from unrelated causes, which can lead to selection bias and weaken the study's validity. ### **High-Yield Clinical Pearls for NEET-PG** * **Gold Standard:** Cohort studies are the best observational design for establishing **temporality** (exposure definitely preceded the outcome). * **Key Metric:** The primary measure of association in a cohort study is **Relative Risk (RR)** and **Attributable Risk (AR)**. * **Rare Exposures:** Cohort studies are excellent for studying rare exposures (e.g., a specific occupational chemical), whereas Case-Control studies are better for rare diseases. * **Incidence:** Cohort studies are the only observational design that can directly calculate the **Incidence** of a disease.

Question 219: What is the isolation period for Hepatitis A?

A. 1 week
B. 2 weeks
C. 3 weeks (Correct Answer)
D. 4 weeks

Explanation: **Explanation:** The isolation period for Hepatitis A is determined by the duration of viral shedding in the feces. In Hepatitis A, the virus is excreted in the stool starting from the latter half of the incubation period, peaking just before the onset of jaundice, and continuing for a short period after. **Why 3 weeks is correct:** According to standard epidemiological guidelines (Park’s Textbook of Preventive and Social Medicine), the period of maximum infectivity occurs during the 2 weeks before the onset of jaundice and persists for at least **1 week after** the onset of jaundice. Therefore, to prevent transmission, a total isolation period of **3 weeks** is recommended (covering the high-risk shedding window). **Analysis of Incorrect Options:** * **1 week:** This only covers the post-icteric shedding phase and ignores the highly infectious prodromal period. * **2 weeks:** While this covers the pre-icteric phase, it fails to account for the continued viral shedding after jaundice appears. * **4 weeks:** This is unnecessarily long for standard isolation, as viral titers in stool drop significantly one week after clinical symptoms manifest. **High-Yield Clinical Pearls for NEET-PG:** * **Mode of Transmission:** Primarily Feco-oral route. * **Incubation Period:** 10–50 days (Average: 28 days). * **Infectivity:** Maximum during the late incubation period (pre-icteric phase). Once jaundice appears, infectivity wanes rapidly. * **Laboratory Diagnosis:** Detection of **IgM anti-HAV** is the gold standard for acute infection. * **Control:** Hand hygiene and the Hepatitis A vaccine (killed vaccine) are the mainstays of prevention. Unlike Hepatitis B, Hepatitis A does not lead to a chronic carrier state or cirrhosis.

Question 220: What is the odds ratio for a 2x2 table with the following structure: | Diagnosis | Diseased | Not diseased | |-------------|----------|--------------| | Positive | a | b | | Negative | c | d |

A. ad/bc (Correct Answer)
B. ab/cd
C. ac/bd
D. bc/ad

Explanation: ### Explanation **1. Why Option A (ad/bc) is Correct:** The **Odds Ratio (OR)** is the standard measure of association used in **Case-Control studies**. It represents the ratio of the odds of exposure among the diseased (cases) to the odds of exposure among the non-diseased (controls). * **Odds of exposure in cases:** $a/c$ (Diseased with positive test vs. Diseased with negative test) * **Odds of exposure in controls:** $b/d$ (Non-diseased with positive test vs. Non-diseased with negative test) * **Calculation:** $OR = (a/c) \div (b/d) = \mathbf{ad/bc}$ This is also known as the **"Cross-Product Ratio"** because it involves multiplying the diagonal cells of a 2x2 table. **2. Why Other Options are Incorrect:** * **Option B (ab/cd):** This is a mathematically incorrect arrangement that does not compare exposure between cases and controls. * **Option C (ac/bd):** This ratio compares the total positive results to total negative results across both groups, which does not define an odds ratio. * **Option D (bc/ad):** This is the inverse of the odds ratio. It would represent the odds of *not* being exposed among cases compared to controls. **3. NEET-PG High-Yield Clinical Pearls:** * **Study Design:** OR is primarily used in Case-Control studies because the prevalence of the disease is not known (the researcher chooses the number of cases and controls). * **Interpretation:** * $OR > 1$: Positive association (Risk factor). * $OR = 1$: No association. * $OR < 1$: Negative association (Protective factor). * **OR vs. Relative Risk (RR):** While RR is used in Cohort studies, OR is a good estimate of RR when the **disease is rare** (the "Rare Disease Assumption"). * **Calculation Tip:** Always ensure "Diseased" are in columns and "Exposed/Positive" are in rows to apply the $ad/bc$ formula correctly.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free